Snisarenko John 4
4 · Oyster Point Pharma, Inc. · Filed Feb 5, 2020
Insider Transaction Report
Form 4
Snisarenko John
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-02-03+72,648→ 72,648 totalExercise: $32.65Exp: 2030-02-02→ Common Stock, par value $0.001 per share (72,648 underlying)
Footnotes (1)
- [F1]Option granted on February 3, 2020 under the Oyster Point Pharma, Inc. 2019 Equity Incentive Plan (the "Plan"). One quarter of the total number of shares subject to the option shall vest one year after January 1, 2020, and one thirty-sixth of the remaining shares shall continue to vest, monthly thereafter, subject to continued service to the Issuer through each such vesting date.